(Q47376890)

15 January 2018

title

MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease (English)

1 reference

15 January 2018

magnetic resonance imaging

0 references

1 reference

0 references

author name string

Paraskevi Kosta

1

1 reference

15 January 2018

Maria I Argyropoulou

2

1 reference

15 January 2018

Sofia Markoula

3

1 reference

15 January 2018

Spyridon Konitsiotis

4

1 reference

15 January 2018

publication date

29 June 2005

1 reference

15 January 2018

published in

Journal of Neurology

1 reference

15 January 2018

volume

253

1 reference

15 January 2018

issue

1

1 reference

15 January 2018

page(s)

26-32

1 reference

15 January 2018

https://scigraph.springernature.com/pub.10.1007/s00415-005-0914-9

exact match

0 references

cites work

T2 relaxation time in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0914-9

Role of iron and ferritin in MR imaging of the brain: a study in primates at different field strengths.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0914-9

Brain hemorrhage: evaluation with fast spin-echo and conventional dual spin-echo images.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0914-9

T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0914-9

Multiexponential proton spin-spin relaxation in MR imaging of human brain tumors.

21 January 2018

1 reference

12 December 2020

Systematic expression of immediate early genes and intensive astrocyte activation induced by intrastriatal ferrous iron injection.

1 reference

12 December 2020

Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla.

1 reference

12 December 2020

Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence.

1 reference

12 December 2020

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

1 reference

12 December 2020

MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects.

1 reference

12 December 2020

Description of Parkinson's disease as a clinical syndrome.

1 reference

12 December 2020

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

1 reference

12 December 2020

Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group

1 reference

12 December 2020

MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease

1 reference

12 December 2020

Topographical and cytological localization of iron in rat and monkey brains

1 reference

12 December 2020

Dopaminergic innervation of human basal ganglia

1 reference

12 December 2020

1 reference

12 December 2020

Basal ganglia iron content in Parkinson's disease measured with magnetic resonance.

1 reference

12 December 2020

Magnetization transfer effects in multislice MR imaging

1 reference

12 December 2020

The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics.

1 reference

12 December 2020

In vivo MR evaluation of age-related increases in brain iron.

1 reference

12 December 2020

Studies on Parkinson's Disease Including X-Ray Fluorescent Spectroscopy of Formalin Fixed Brain Tissue

1 reference

12 December 2020

Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states

1 reference

12 December 2020

Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy.

1 reference

12 December 2020

Criteria for diagnosing Parkinson's disease

1 reference

12 December 2020

Age distribution and iron dependency of the T2 relaxation time in the globus pallidus and putamen.

1 reference

12 December 2020

The regional distribution and cellular localization of iron in the rat brain

1 reference

12 December 2020

Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson's disease

1 reference

12 December 2020

Biochemical fundamentals of Parkinson's disease

1 reference

12 December 2020

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

1 reference

12 December 2020

Brain iron and ferritin in Parkinson's and Alzheimer's diseases.

1 reference

12 December 2020

Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes

1 reference

12 December 2020

Altered brain metabolism of iron as a cause of neurodegenerative diseases?

1 reference

12 December 2020

MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease.

1 reference

12 December 2020

Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains

1 reference

12 December 2020

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia

1 reference

12 December 2020

The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings.

1 reference

12 December 2020

Iron concentration reduced in ventral pallidum, globus pallidus, and substantia nigra by GABA-transaminase inhibitor, gamma-vinyl GABA.

1 reference

12 December 2020

Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease

1 reference

12 December 2020

10.1007/S00415-005-0914-9

Identifiers

DOI

1 reference

15 January 2018

1 reference

15 January 2018